Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas
Clinical trial NCT01143545 · TERMINATED
Trial details
- NCT number
- NCT01143545
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-07
- Primary completion
- 2015-02-09
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.